Identification of epigenetic modulators as determinants of nuclear size and shape.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
23 May 2023
Historique:
received: 29 05 2022
accepted: 04 05 2023
medline: 12 6 2023
pubmed: 23 5 2023
entrez: 23 5 2023
Statut: epublish

Résumé

The shape and size of the human cell nucleus is highly variable among cell types and tissues. Changes in nuclear morphology are associated with disease, including cancer, as well as with premature and normal aging. Despite the very fundamental nature of nuclear morphology, the cellular factors that determine nuclear shape and size are not well understood. To identify regulators of nuclear architecture in a systematic and unbiased fashion, we performed a high-throughput imaging-based siRNA screen targeting 867 nuclear proteins including chromatin-associated proteins, epigenetic regulators, and nuclear envelope components. Using multiple morphometric parameters, and eliminating cell cycle effectors, we identified a set of novel determinants of nuclear size and shape. Interestingly, most identified factors altered nuclear morphology without affecting the levels of lamin proteins, which are known prominent regulators of nuclear shape. In contrast, a major group of nuclear shape regulators were modifiers of repressive heterochromatin. Biochemical and molecular analysis uncovered a direct physical interaction of histone H3 with lamin A mediated via combinatorial histone modifications. Furthermore, disease-causing lamin A mutations that result in disruption of nuclear shape inhibited lamin A-histone H3 interactions. Oncogenic histone H3.3 mutants defective for H3K27 methylation resulted in nuclear morphology abnormalities. Altogether, our results represent a systematic exploration of cellular factors involved in determining nuclear morphology and they identify the interaction of lamin A with histone H3 as an important contributor to nuclear morphology in human cells.

Identifiants

pubmed: 37219077
doi: 10.7554/eLife.80653
pii: 80653
pmc: PMC10259489
doi:
pii:

Substances chimiques

Histones 0
Lamin Type A 0
Nuclear Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : NIH R35GM134885
Pays : United States
Organisme : NIH HHS
ID : NIH P20GM103432
Pays : United States
Organisme : NIH HHS
ID : NIH 1-ZIA-BC010309-23
Pays : United States
Organisme : NIH HHS
ID : NIH 1-ZIC-BC011567-08
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM134885
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103432
Pays : United States
Organisme : NIH HHS
ID : NIH 1-ZIA-BC010309-23
Pays : United States
Organisme : NIH HHS
ID : NIH 1-ZIC-BC011567-08
Pays : United States
Organisme : NIH HHS
ID : NIH R35GM134885
Pays : United States
Organisme : NIH HHS
ID : NIH P20GM103432
Pays : United States

Déclaration de conflit d'intérêts

AS, PJ, GP, DL, TM No competing interests declared

Références

Curr Biol. 2006 Mar 21;16(6):543-52
pubmed: 16458513
Nat Cell Biol. 2021 Feb;23(2):116-126
pubmed: 33558730
Klin Khir (1962). 1991;(2):24-6
pubmed: 2056687
EMBO Rep. 2019 Jun;20(6):
pubmed: 31085625
Science. 2006 May 19;312(5776):1059-63
pubmed: 16645051
Mol Biol Cell. 2019 Aug 1;30(17):2320-2330
pubmed: 31365328
PLoS One. 2013;8(2):e55628
pubmed: 23405182
Annu Rev Cell Dev Biol. 2012;28:113-35
pubmed: 22804576
J Biol Chem. 2013 Mar 22;288(12):8610-8618
pubmed: 23355469
Mol Biol Cell. 2011 Dec;22(23):4683-93
pubmed: 21976703
Cancer Res. 2011 Jul 1;71(13):4550-61
pubmed: 21555372
J Struct Biol. 2011 Sep;175(3):425-33
pubmed: 21635954
Commun Integr Biol. 2021 Jul 5;14(1):158-175
pubmed: 34262635
PLoS One. 2008 Aug 20;3(8):e2988
pubmed: 18714339
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8703-8
pubmed: 16738054
Ageing Res Rev. 2021 May;67:101264
pubmed: 33540043
FEBS J. 2013 Dec;280(23):6223-32
pubmed: 24112551
FEBS Lett. 2011 Jul 7;585(13):2024-31
pubmed: 21074527
Nature. 2003 May 15;423(6937):293-8
pubmed: 12714972
J Cell Sci. 2016 Mar 15;129(6):1115-27
pubmed: 26823604
Cell. 2014 Jan 30;156(3):400-7
pubmed: 24485450
Clin Neuropathol. 2003 May-Jun;22(3):129-36
pubmed: 12809355
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):245-50
pubmed: 20056644
Genome Med. 2014 Feb 27;6(2):18
pubmed: 24576404
J Clin Invest. 2004 Feb;113(3):370-8
pubmed: 14755334
Cold Spring Harb Perspect Med. 2017 Jan 3;7(1):
pubmed: 27864305
Aging Cell. 2022 Jan;21(1):e13521
pubmed: 34894056
J Biol Chem. 2015 Nov 13;290(46):27557-71
pubmed: 26429910
Mol Biol Cell. 2010 Jan 15;21(2):354-68
pubmed: 19940018
Curr Biol. 2015 Jan 5;25(1):45-52
pubmed: 25484296
J Cell Biol. 1999 Mar 22;144(6):1083-96
pubmed: 10087255
Chromosoma. 2012 Apr;121(2):153-67
pubmed: 22307332
Nucleus. 2011 May-Jun;2(3):168-72
pubmed: 21818409
Mol Biol Cell. 2020 Jun 15;31(13):1392-1402
pubmed: 32320319
Semin Cell Dev Biol. 2022 Oct;130:90-97
pubmed: 34776332
Nat Rev Cancer. 2012 Feb 16;12(3):196-209
pubmed: 22337151
Nucleic Acids Res. 2021 Dec 2;49(21):12136-12151
pubmed: 34788845
Int J Mol Sci. 2013 Sep 10;14(9):18670-81
pubmed: 24025425
Plant J. 2011 May;66(4):629-41
pubmed: 21294795
Cell. 1995 Jul 14;82(1):47-56
pubmed: 7606784
Nat Cell Biol. 2019 Oct;21(10):1248-1260
pubmed: 31576060
Nucleic Acids Res. 2023 Jan 6;51(D1):D638-D646
pubmed: 36370105
Nat Commun. 2019 Apr 23;10(1):1871
pubmed: 31015410
Curr Opin Genet Dev. 2021 Apr;67:163-173
pubmed: 33774266
FEBS J. 2021 May;288(9):2757-2772
pubmed: 32799420
FEBS Lett. 2010 Jul 16;584(14):2999-3004
pubmed: 20580717
Nucleus. 2010 Sep-Oct;1(5):432-9
pubmed: 21326826
Am J Pathol. 1996 Jan;148(1):313-9
pubmed: 8546221
Dev Cell. 2020 Aug 10;54(3):395-409.e7
pubmed: 32473090
Clin Cancer Res. 1999 Nov;5(11):3542-8
pubmed: 10589770
Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):8963-8
pubmed: 15184648
Proc Natl Acad Sci U S A. 1979 Oct;76(10):4857-61
pubmed: 291904
PLoS Genet. 2019 Feb 13;15(2):e1007929
pubmed: 30759079
Nat Rev Cancer. 2004 Sep;4(9):677-87
pubmed: 15343274
Pathologe. 1996 Jan;17(1):18-25
pubmed: 8685092
Cancer Res. 2011 Mar 1;71(5):1752-62
pubmed: 21216892
Gut. 1999 Nov;45(5):723-9
pubmed: 10517909
J Biomol Screen. 2003 Dec;8(6):634-47
pubmed: 14711389
Cell. 2010 Oct 15;143(2):288-98
pubmed: 20946986
BMB Rep. 2018 Jul;51(7):327-337
pubmed: 29764566
Nat Commun. 2012 Feb 14;3:671
pubmed: 22334074
Genome Biol. 2006;7(7):R66
pubmed: 16869968
Nucleus. 2016 Apr 25;7(2):167-86
pubmed: 26963026
J Cell Biol. 2007 Nov 19;179(4):593-600
pubmed: 17998401
Nat Cell Biol. 2011 Aug 21;13(9):1051-61
pubmed: 21857669
Cancer. 1991 Nov 1;68(9):2012-6
pubmed: 1655233
Mol Biol Cell. 2017 Jul 7;28(14):1984-1996
pubmed: 28057760
Genes Dev. 2001 Sep 15;15(18):2343-60
pubmed: 11562345
Biochemistry. 2003 May 6;42(17):4819-28
pubmed: 12718522
Cell Mol Life Sci. 2012 Oct;69(20):3493-509
pubmed: 22653047
Am J Pathol. 1993 Jul;143(1):211-20
pubmed: 8391215
J Cell Sci. 2008 Jun 1;121(11):1887-98
pubmed: 18477613
Cell. 2012 Jul 6;150(1):122-35
pubmed: 22770216
Acta Neuropathol. 2012 Sep;124(3):439-47
pubmed: 22661320
Nat Struct Mol Biol. 2016 Jun;23(6):540-8
pubmed: 27159561
Curr Biol. 2009 May 26;19(10):843-7
pubmed: 19375312
Mol Biol Cell. 2018 Jan 15;29(2):220-233
pubmed: 29142071
Gut. 2015 Apr;64(4):636-45
pubmed: 24951259
Annu Rev Pathol. 2022 Jan 24;17:159-180
pubmed: 34672689
Nature. 2012 Jan 29;482(7384):226-31
pubmed: 22286061
Genome Biol. 2011;12(5):222
pubmed: 21639948
J Struct Biol. 2006 Aug;155(2):351-60
pubmed: 16697219
Antioxid Redox Signal. 2013 Aug 1;19(4):415-30
pubmed: 22793999
Breast J. 1999 Mar;5(2):122-129
pubmed: 11348271
Nat Genet. 1999 Mar;21(3):285-8
pubmed: 10080180
J Cell Biol. 2014 Aug 18;206(4):473-83
pubmed: 25135933
Sci Adv. 2020 Dec 2;6(49):
pubmed: 33268356
PLoS Genet. 2017 May 18;13(5):e1006767
pubmed: 28545058
J Cell Sci. 2012 Dec 1;125(Pt 23):5702-10
pubmed: 22992461
Hum Mol Genet. 2007 Dec 1;16(23):2816-33
pubmed: 17761684
Science. 2003 Jun 27;300(5628):2055
pubmed: 12702809
Curr Opin Cell Biol. 2019 Jun;58:76-84
pubmed: 30889417
Chromosoma. 2017 Mar;126(2):195-212
pubmed: 27631793
Annu Rev Genomics Hum Genet. 2020 Aug 31;21:263-288
pubmed: 32428417
Trends Cell Biol. 2018 Jan;28(1):34-45
pubmed: 28893461
Nat Genet. 2013 Dec;45(12):1479-82
pubmed: 24162739

Auteurs

Andria C Schibler (AC)

National Cancer Institute, Bethesda, United States.

Predrag Jevtic (P)

Department of Molecular Biology, University of Wyoming, Laramie, United States.

Gianluca Pegoraro (G)

High Throughput Imaging Facility (HiTIF), National Cancer Institute, NIH, Bethesda, United States.

Daniel L Levy (DL)

Department of Molecular Biology, University of Wyoming, Laramie, United States.

Tom Misteli (T)

National Cancer Institute, Bethesda, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH